 LOS ANGELES--BUSINESS WIRE--- CDXC CellularHealth--ChromaDex Corp. NASDAQ: CDXC announced today that it has entered into a securities purchase agreement for the sale of 25.0 million of its common stock in a private placement. The private placement was led by a new international investor and is expected to close on or about February 23, 2021, subject to the satisfaction of customary closing conditions. In connection with the investment, the Company agreed to sell 3,846,153 shares of its common stock at a per shar 